Deferred cytoreductive nephrectomy in kidney cancer fails to improve progression-free survival
Results from the phase 3 CARMENA study, published in the [...]
Advances and next steps in kidney cancer
In an interview with OncLive, Dr Toni Choueiri from Harvard Medical [...]
Prognostic markers for kidney cancer
A recent study published in the Lancet Oncology has identified that [...]
Exercise significantly cuts the risk of death from cancer
New research from an American group based at Roswell Park [...]
Cancer drugs taking longer to reach NHS patients
A new report by the Institute of Cancer Research (ICR) [...]
First NHS cancer patient to begin treatment with proton beam therapy in Manchester
Cally Palmer, NHS England's national cancer director announced at the [...]
Comparison of axitinib and sunitinib as first-line treatment for metastatic kidney cancer
This multicentre analysis of axitinib versus sunitinib used as first-line [...]
Robot-assisted surgery available in East Lancashire
Three talented surgeons have performed what is believed to be [...]
Nivolumab-ipilimumab combination delays the need for additional treatment in kidney cancer patients
A recent analysis of data from the phase 3 Checkmate-214 [...]
Results from JAVELIN Renal 101 clinical trial – avelumab plus axitinib combination for advanced kidney cancer
The following article from Practice Update discusses the JAVELIN Renal [...]
